• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Dialectical Behavior Therapy Tied to Fewer Suicide Attempts

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, Sept. 19, 2023 -- Dialectical behavior therapy (DBT) is effective for decreasing suicide attempts among adolescents with bipolar spectrum disorder, according to a study published online Sept. 13 in JAMA Psychiatry.

Tina R. Goldstein, Ph.D., from University of Pittsburgh, and colleagues randomly assigned adolescents (aged 12 to 18 years) diagnosed with bipolar spectrum disorder to one year of DBT (36 sessions; 47 patients) or standard-of-care (SOC) psychotherapy (schedule clinically determined; 53 patients).

During a mean follow-up of 47 weeks, both groups showed significant and similar improvement in mood symptoms and episodes. During follow-up, DBT participants reported significantly fewer suicide attempts versus SOC participants using the Adolescent Longitudinal Follow-Up Evaluation (mean attempts per follow-up period, 0.2 versus 1.1, when controlling for baseline attempts) and using the Columbia-Suicide Severity Rating Scale Pediatric Version (mean attempts per follow-up period, 0.04 versus 0.10, when controlling for baseline attempts). However, the decreased rate of suicide attempts in the DBT group was moderated by presence of lifetime history of suicide attempt and time (incident rate ratio, 0.23) and mediated by improvement in emotion dysregulation (incident rate ratio, 0.61), particularly for those with high baseline emotion dysregulation.

"These findings support DBT as the first psychosocial intervention with demonstrated effects on suicidal behavior for adolescents with bipolar spectrum disorder," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2023

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.